One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition that can lead to sudden vision loss due to lack of blood flow.

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with type 2 diabetes and found a potential link between weight loss drug and rare by serious eye problem.

Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly higher risk of certain eye problems.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye complications

Have you noticed how many people are turning to new medicines to help lose weight? These drugs, like Ozempic and Wegovy, have become very popular. But what if they come with risks that affect something as important as your sight?